Teva BV and Teva Finland Oy v. Merck Sharp & Dohme LLC and Merck Sharp & Dohme LLC v. Clonmel Healthcare Limited Regulation (EC) No 469/2009, Art. 3(a) and (c)
Springer Nature ·
2025-04-17
· DOI 10.1007/s40319-025-01599-0
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Teva BV and Teva Finland Oy v. Merck Sharp & Dohme LLC and Merck Sharp & Dohme LLC v. Clonmel Healthcare Limited Regulation (EC) No 469/2009, Art. 3(a) and (c). “Teva and Teva Finland”. // IIC - International Review of Intellectual Property and Competition Law. – 2025. – DOI: 10.1007/s40319-025-01599-0. – URL: https://doi.org/10.1007/s40319-025-01599-0
Teva BV and Teva Finland Oy v. Merck Sharp & Dohme LLC and Merck Sharp & Dohme LLC v. Clonmel Healthcare Limited Regulation (EC) No 469/2009 & Art. 3(a) and (c) (2025). “Teva and Teva Finland”. IIC - International Review of Intellectual Property and Competition Law. https://doi.org/10.1007/s40319-025-01599-0
Teva BV and Teva Finland Oy v. Merck Sharp & Dohme LLC and Merck Sharp & Dohme LLC v. Clonmel Healthcare Limited Regulation (EC) No 469/2009 and Art. 3(a) and (c). ““Teva and Teva Finland”.” IIC - International Review of Intellectual Property and Competition Law, 2025. doi:10.1007/s40319-025-01599-0.
@article{article208952,
title = {“Teva and Teva Finland”},
author = {469/2009, Teva BV and Teva Finland Oy v. Merck Sharp \& Dohme LLC and Merck Sharp \& Dohme LLC v. Clonmel Healthcare Limited Regulation (EC) No and (c), Art. 3(a) and},
journal = {IIC - International Review of Intellectual Property and Competition Law},
year = {2025},
doi = {10.1007/s40319-025-01599-0},
url = {https://doi.org/10.1007/s40319-025-01599-0}
}